Cell Biosciences

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Paired Ends

Premium

Sam Mohan

The protein analysis firm also said that it raised $13 million in connection with the deal.

New Products

Premium

Cell Biosciences

Paired Ends

Premium

Mark Dronsfield, Bernd Brust, Jeremy Berg, Mark Poznansky

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

Paired Ends

Premium

Lloyd Kunimoto, Martin Burow, Richard Lussier, Ingrid Choupin

With the assay, the Stanford researchers have begun examining protein phosphorylation levels in a variety of cancer types. The team has also entered into collaborations with several pharmaceutical firms to investigate the effects of therapeutic agents on protein phosphorylation levels in tumor cells.

The deal is expected to expand Cell Biosciences' protein analysis product portfolio "and transform Cell Biosciences into the premier provider of capillary-based protein analysis technology," the company said.

New Products

Premium

Cell Biosciences, Proteome Software, TTP LabTech

Pages

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.